GLP-1 Maintenance Dosing: What Happens After You Reach Your Goal

Last updated: 8 August 2026

TL;DR: Maintenance dosing is the phase after active weight loss, where the goal shifts from losing weight to holding it. Evidence shows that continuing treatment, in some cases at a lower dose, preserves most of the weight lost, while stopping tends to lead to regain. The right maintenance dose is the lowest one that keeps weight stable for you, decided with a prescriber.

Most guidance covers how to start a weight loss injection. Far less explains what happens once you reach your goal, which is where many patients have their most important questions. Maintenance is a distinct phase with its own logic, and this guide explains it, grounded in the clinical evidence. It is educational and does not replace advice from your prescriber.

What Is GLP-1 Maintenance Dosing?

Maintenance dosing is the ongoing dose used to keep weight stable after the active loss phase, rather than to drive further loss. The aim changes: from reducing weight to preventing it returning. For some people that means continuing at their existing dose; for others it can mean stepping down to a lower dose that still holds the result.

Obesity is increasingly understood as a long-term condition, which is why maintenance is framed as continued management rather than a finish line. The medicine addresses a biological driver of weight; when the treatment stops, that driver typically returns, and the next sections explain what the trials show.

How Do Clinicians Decide When to Move to Maintenance?

The move to maintenance is usually considered once weight has stabilised near a person's goal and the priority becomes holding it steadily over time. It is a clinical judgement based on weight trend, how well the current dose is tolerated, and the individual's health picture, not a fixed timetable.

Dose reduction can be part of this. According to SURMOUNT-MAINTAIN (The Lancet, 2026), continuing tirzepatide, including at a reduced maintenance dose, preserved a substantial proportion of the weight lost compared with stopping, where participants regained weight. The practical implication is that maintenance is negotiated to the lowest dose that keeps you stable, which the positioning of GLP-1 treatment increasingly reflects: the target is the dose that becomes sustainable, not the maximum.

Do You Have to Stay on Weight Loss Medication Long Term?

For most people, keeping the weight off means staying on some level of treatment, because the biological drivers of weight return when the medicine is withdrawn. This is one of the most important and least understood facts about GLP-1 treatment.

According to a maintenance trial of continued weekly semaglutide versus placebo (Rubino et al., JAMA, 2021), people who continued treatment maintained and extended their weight loss, while those switched to placebo regained a meaningful proportion of it. A 2025 narrative review of randomised studies reached the same broad conclusion across semaglutide, tirzepatide and liraglutide: interrupting treatment is generally followed by weight regain. That does not mean treatment must be lifelong for everyone, but it reframes stopping as a planned clinical decision, not a default endpoint.

How Does Maintenance Fit Into Everyday Life?

Maintenance is where the medication becomes routine and the day-to-day habits built during weight loss do the ongoing work. A lower or steady dose sits alongside the eating, movement and sleep patterns established earlier, and the two reinforce each other.

• Keep the protein, fibre and portion habits that worked during active loss.
• Maintain regular movement; more activity can support a lower effective dose.
• Track non-scale markers (energy, measurements, clothing) alongside weight.
• Keep scheduled reviews with your prescriber to adjust the dose as needed.

The aim is a maintenance routine that fits your life rather than dominates it. See the related lifestyle guides for the eating and movement side of this phase.

What Support Should a Pharmacy Provide During Maintenance?

Good maintenance care is active, not a repeat prescription on autopilot. It means periodic clinical review, a named prescriber you can reach with questions, and willingness to adjust the dose as your weight, tolerance and goals change.

Bolt Pharmacy operates a named-prescriber model with structured clinical review, which is designed for exactly this phase: an ongoing relationship rather than a one-off transaction. If you are approaching your goal or thinking about the long term, maintenance is worth planning with your prescriber rather than deciding alone.

Related Guides

• Coming Off Weight Loss Medication: How to Reduce the Risk of Weight Regain
• Life After the First Dose: A Practical Guide to Long-Term GLP-1 Routines
• How to Build Sustainable Eating Habits While on GLP-1 Medication
• GLP-1 and Muscle Loss: How to Protect Lean Mass During Weight Loss
• How Bolt Prescribes: Our Clinical Process

Key Takeaways

• Maintenance dosing keeps weight stable after the active loss phase; the goal shifts from losing to holding.
• Continuing treatment, sometimes at a lower dose, preserves most of the weight lost in trials.
• SURMOUNT-MAINTAIN showed reduced-dose tirzepatide held weight well versus regain on stopping.
• Stopping treatment is generally followed by weight regain because the biological drivers return.
• The best maintenance dose is the lowest that keeps you stable, decided with a prescriber.
• Habits built during weight loss do much of the ongoing maintenance work.

Frequently Asked Questions

What is a maintenance dose of Mounjaro or Wegovy?
It is the ongoing dose used to hold your weight stable after you reach your goal, rather than to lose more. For some people it is their existing dose; for others it can be a lower dose. The right one is the lowest dose that keeps weight steady, set with a prescriber.

Do I have to stay on weight loss medication forever?
Not necessarily, but keeping the weight off usually means staying on some level of treatment, because the biological drivers of weight return when it stops. Stopping should be a planned clinical decision with your prescriber, not an automatic endpoint.

Can I lower my dose once I reach my goal?
Often, yes. Evidence from SURMOUNT-MAINTAIN (2026) showed a reduced maintenance dose of tirzepatide preserved most of the weight lost compared with stopping. Any dose change should be made with your prescriber based on your weight trend and tolerance.

Will I regain weight on a maintenance dose?
The point of maintenance dosing is to prevent regain, and trials show continued treatment holds most of the loss. Weight can still drift if habits slip, which is why maintenance combines the dose with the eating and activity routines built during weight loss.

Published by Bolt Pharmacy, a GPhC-registered UK pharmacy. Sources: SURMOUNT-MAINTAIN, The Lancet (2026); Rubino et al., JAMA (2021); narrative review of weight regain after GLP-1 interruption (2025). Educational only; not a substitute for advice from your prescriber. Reflects published information as of August 2026.